RxSight, Inc.
For the period ended Mar 31, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Securities Trading Plans of Directors and Executive Officers
During our last fiscal quarter, none of our directors or officers, as defined in Rule 16a-1(f), adopted and/orterminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Regulation S-K Item 408.
Scott Gaines — Consulting Transition
On May 5, 2026, the Company and Scott Gaines, the Company’s Chief Customer Officer, agreed that Mr. Gaines would transition from employee to consultant status and would cease to serve as an executive officer of the Company, in each case effective immediately. As a consultant, Mr. Gaines will continue to vest in his currently-held stock options and restricted stock units according to their current vesting schedules. The term of the consulting arrangement will for a term of one year, subject to renewal.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.